跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
斯沃 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Linezolid and Glucose Injection
Approved
化学药品
Linezolid and Glucose Injection
Pfizer AS
🇨🇳 National Medical Products Administration
Approval Date
Sep 18, 2020
Approval ID
888WFw0LsB6
Company
Pfizer AS
Type
化学药品
Approval Details
Approval Id
888WFw0LsB6
Approval Number
国药准字HJ20160272
Generic Name
利奈唑胺葡萄糖注射液
Generic Name En
Linezolid and Glucose Injection
Trade Name
斯沃
Drug Type
化学药品
Dosage Form
注射剂
Strength
100ml∶利奈唑胺0.2g与葡萄糖5.0g
Reg Date
2020-09-18
Expired Date
2025-09-17
Company Name
Pfizer AS
Company Address
P.O.Box 3,1324 Lysaker,Norway
Production Company Name
Fresenius Kabi Norge AS
Production Company Address
P.O.Box 430,1753 Halden,Norway
Company Detail Path
/organization/pfizer-as
Production Company Detail Path
/organization/fresenius-kabi-norge-as
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 18, 2020
Approval ID
888WFw0LsB6
Type
化学药品
Back to NMPA Approvals